期刊文献+

吸烟患者冠状动脉旁路移植术中血浆15-F_(2t)-isoprostane浓度变化及其临床意义

Change in plasma free 15-F_(2t)-isoprostane concentration in smoking patients undergoing coronary artery bypass grafting and its clinical significance
下载PDF
导出
摘要 目的 观察体外循环冠状动脉 (冠脉 )旁路移植术中吸烟患者血浆 15 F2 t isoprostane(15 F2 t Iso P)的变化及其与术后心功能恢复的关系。方法 选择 30例吸烟冠心病患者及 30例非吸烟冠心病患者 ,均在异丙酚、芬太尼复合麻醉及体外循环下行冠脉旁路移植术。分别于麻醉诱导后手术前 (T0 )、主动脉阻断后 30 m in(T1)、主动脉开放后 10 min(T2 )及 30 m in(T3)经中心静脉抽血 ,测血浆游离 15 F2 t Iso P浓度。结果  T0时吸烟及非吸烟组血浆 15 F2 t Iso P浓度差异无显著性。T1时两组血浆 15 F2 t Iso P显著升高 (与 T0比较 ,P均 <0 .0 1) ,此时吸烟组 15 F2 t Iso P的升高幅度显著高于非吸烟组 (P<0 .0 5 )。再灌注期 (T2、T3)吸烟组血浆 15 F2 t Iso P浓度下降速度较非吸烟组为慢 ,术后更多患者需血管活性药物支持。结论 吸烟者体内抗氧化能力降低 ,增加了心脏手术后心功能障碍的发生率。 Objective To investigate the change in plasma free 15F 2t isoprostane (15F 2t IsoP) concentration and its relationship with postoperative cardiac function of smoking patients who underwent coronary artery bypass grafting(CABG). Methods Sixty patients with coronary artery heart disease were divided into smoking group 〔 n =30, age 5469 years old, American Heart Association(AHA)ⅡⅢ〕 and nonsmoking group( n =30, age 5870 years old, ASA ⅡⅢ). All the patients were scheduled for CABG under combination anesthesia with isoflurane and fentanyl and conventional cardiopulmonary bypass. Blood samples were drawn from the central vein to measure 15F 2t IsoP at the following time points: before operation(T0) ; 30 minutes after aortic clamping for cardiopulmonary bypass(T1); 10 and 30 minutes after aortic declamping(T2,T3). Results There was no statistical difference in 15F 2t IsoP between two groups at T0, but contents of 15F 2t IsoP in the two groups was increased markedly at T1, compared to those at T0( P <0 05 and P <0 01 for smoking and nonsmoking groups, respectively), and the degree of increase of 15F 2t IsoP in smoking group was significantly higher than that in nonsmoking group( P <0 05). During reperfusion period (at T2,T3), the rate of lowering of 15F 2t IsoP in smoking group was slower than that in nonsmoking group( P <0 05), and moreover, these patients needed more inotropic support than those in nonsmoking group. Conclusion Smoking patients have weaker antioxidation capability during CABG, therefore they have higher incidence of low cardiac function.
出处 《中国危重病急救医学》 CAS CSCD 北大核心 2005年第3期165-167,共3页 Chinese Critical Care Medicine
基金 广东省深圳市科研基金重点资助项目 (2 0 0 3 0 4175 )
关键词 吸烟 冠状动脉旁路移植术 血浆 15-F2t-isoprostane 浓度检测 心功能 smoking coronary artery bypass grafting 15-F_(2t)-isoprostane postoperative cardiac function
  • 相关文献

参考文献10

  • 1Morrow J D,Awad J A,Blair I A,et al. Non- cyclooxygenasederived prostanoids (F2 -isoprostanes) are formed in situ on phospholipids [J]. Proc Natl Acad Sci USA, 1992, 89:10721 -10725.
  • 2Morrow J D, Roberts L J. The isoprostanes: unique bioactive products of lipid peroxidation [J]. Prog Lipid Res, 1997, 36:1 -21.
  • 3Ansley D M, Xia Z, Dhaliwal B S. The relationship between plasma free 15 - F2t- isoprostane concentration and early postoperative cardiac depression following warm heart surgery[J].Thorac Cardiovasc Surg, 2003,126: 1222 - 1223.
  • 4Clermont G, Vergely C,Jazayeri S, et al. Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass [J]. Anesthesiology, 2002,96 :80 - 87.
  • 5Xia Z,Godin D V,Chang T K,et al. Dose -dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats:effects on 15 -F2t-isoprostane formation[J]. Can J Physiol Pharmaco1,2003,81 : 14 - 21.
  • 6Roberts L J, Morrow J D. The generation and actions of isoprostanes [J]. Biochem Biophys Acta, 2000,1345 : 121 - 135.
  • 7Pratico D,Lawson J A,Rokach J,et al. The isoprostanes in biology and medicine [J]. Trends Endocrinol Metab, 2001,12:243 -247.
  • 8黄志勇,夏正远,David M. Ansley,Baljinder.冠状动脉搭桥患者围术期血浆15-F_(2t)-isoprostane含量变化及临床意义[J].中国危重病急救医学,2004,16(3):165-168. 被引量:8
  • 9Reilly M,Delanty N,Lawson J A,et al. Modulation of oxidant stress in vivo in chronic cigarette smokers[J]. Circulation, 1996,94:19 -25.
  • 10Basu S. Metabolism of 8- iso- prostaglandin F2α[J]. FEBS Letter, 1998,428:32 - 36.

二级参考文献20

  • 1Xia Zhengyuan, Godin D V, Ansley D M. Propofol enhancesis chemic tolerance of middle- aged rat hearts: effects on 15-F2t-isoprostane formation and tissue antioxidant capacity[J]. Cardiovascular Research, 2003,59 .- 113 - 121.
  • 2Yau T M,Ikonomidis J S,Weisel R D,et al. Ventricular function after normothermic versus hypothermic cardioplegia[J]. J Thorac Cardiovasc Surg, 1993,105 : 833 - 844.
  • 3Laffey J G,Boylan J F,Cheng D C H. The systemic inflammatory response to cardiac surgery -implications for the anesthesiologist [J]. Anesthesiology, 2002,97 : 215 - 252.
  • 4Roberts L J, Morrow J D. The generation and actions of isoprostanes [J]. Biochim Biophys Acta, 2000,1345 (2) : 121 - 135.
  • 5Iuliano L, Pratico D, Greco C, et al. Angioplasty increases coronary sinus F2- isoprostane formation :evidence for in vivo oxidative stress during PTCA [J]. J Am Coll Cardiol, 2001, 37:76 - 80.
  • 6Mori T A,Croft K D,Puddey I B,et al. An improved method for the measurement of urinary and plasma F2 -isoprostanes using gas chromatography- mass spectrometry [J]. Ann Biochem,2001,270.- 117 - 125.
  • 7Mehrabi M R, Ekmekcioglu C, Tatzber F ,et al. The isoprostane 8 -epi -PGF2α,is accumulated in coronary arteries isolated fromp atients with coronary artery disease[J]. Cardiovascular Research, 1999,43 : 492 - 499.
  • 8Rao V, Ivanov J, Weisel R D, et al. Predictors of low cardiac output syndrome after coronary artery bypass [J]. J Thorac Cardiovasc Surg, 1996,112 : 38 - 51.
  • 9Rao V,Ivanov J,Weisel R D,et al.Predictors of low cardiac output syndrome after coronary artery bypass[J].J Thorac Cardiovasc Surg,1996,112:38-51.
  • 10Xia Zhengyuan,Godin D V,Ansley D M.Propofol enhances ischemic tolerance of middle-aged rat hearts:effects on 15-F2t-isoprostane formation and tissue antioxidant capacity[J].Cardiovascular Research,2003,59:113-121.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部